Merrimack Pharma

BiotechnologySeries GCambridge, USmerrimackpharma.com

Latest round

Series G

Last raised

Apr 2011

Total raised

$258M

Investors

12

About Merrimack Pharma

Founded in 1993, Merrimack Pharmaceuticals is based in Cambridge, US, and specializes in oncology therapies. The company underwent a significant pivot in 2025 towards human growth hormone therapies.Merrimack Pharmaceuticals, alongside Allied BioScience, offers oncology therapies and human growth hormone (HGH) therapies. Its flagship product, Onivyde®, is an FDA-approved treatment for metastatic pancreatic cancer, launched in 2015. The company has expanded its focus to include HGH therapies, addressing health needs related to growth and metabolism.04 mn. The company aims to expand into new markets, focusing on strategic geographic regions in North America, Europe, and Asia by 2025, enhancing its reach and product offerings.

Who invested in Merrimack Pharma

12 investors across 5 rounds

See all investors in Merrimack Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series G

    Apr 13, 2011

    Amount

    $77M

    Investors

    Locked

  2. Series F

    Jun 10, 2008

    Amount

    $60M

    Investors

    Locked

  3. Series E

    Apr 3, 2006

    Amount

    $65M

    Investors

    Locked

  4. Series D

    Feb 7, 2005

    Amount

    $28M

    Investors

    Locked

  5. Series C

    May 4, 2004

    Amount

    $28M

    Investors

    Locked

Questions about Merrimack Pharma

Who invested in Merrimack Pharma?

Merrimack Pharma has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Merrimack Pharma raised?

Merrimack Pharma has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Merrimack Pharma last raise money?

Merrimack Pharma's most recent round on record is a Series G, in Apr 2011.

What does Merrimack Pharma do?

Founded in 1993, Merrimack Pharmaceuticals is based in Cambridge, US, and specializes in oncology therapies.

Where is Merrimack Pharma headquartered?

Merrimack Pharma is headquartered in Cambridge, US.

Which VCs invest in companies like Merrimack Pharma?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Merrimack Pharma's stage. Their profiles are linked below.

Raising like Merrimack Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.